We are live on
!
Find out more
RXII
GALENA BIOPHARMA INC COM
RXII
RXII
Delisted
RXII was delisted on the 25th of October, 2011.
91 hedge funds and large institutions have $11.5M invested in GALENA BIOPHARMA INC COM in 2016 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
774% more call options, than puts
Call options by funds: $3.66M | Put options by funds: $419K
1% more funds holding
Funds holding: 90 → 91 (+1)
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
9% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 23
20% less capital invested
Capital invested by funds: $14.4M → $11.5M (-$2.83M)
Holders
91
Holders Change
+1
Holders Change %
+1.11%
% of All Funds
2.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
25
Reduced
23
Closed
11
Calls
$3.66M
Puts
$419K
Net Calls
+$3.25M
Net Calls Change
+$144K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$517K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$437K |
| 3 |
Goldman Sachs
New York
|
+$434K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$86.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$45.9K |
